Ke Li
Corporate Officer/Principal bei Shenyang Sunshine Pharmaceuticals Co., Ltd.
Profil
Ke Li is a professional who has worked as a Vice President at Shenyang Sunshine Pharmaceuticals Co., Ltd.
since 1993.
Prior to this, Mr. Li worked as a Vice President at 3SBio, Inc. Mr. Li received an undergraduate degree from Jilin University in 1988 and another undergraduate degree from Liaoning University in 2001.
Aktive Positionen von Ke Li
| Unternehmen | Position | Beginn |
|---|---|---|
Shenyang Sunshine Pharmaceuticals Co., Ltd.
 Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Corporate Officer/Principal | 01.03.1993 |
Ehemalige bekannte Positionen von Ke Li
| Unternehmen | Position | Ende |
|---|---|---|
| 3SBIO INC. | Corporate Officer/Principal | - |
Ausbildung von Ke Li
| Jilin University | Undergraduate Degree |
| Liaoning University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| 3SBIO INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Health Technology |
